Chiron Investment Management, LLC Eli Lilly & CO Transaction History

Chiron Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $232,891 - $311,402	664 New	664 $311,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $8.43 Million - $9.6 Million	28,420 New	28,420 $9.19 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.5 Million - $1.84 Million	-6,750 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $1.22 Million - $1.58 Million	6,750 New	6,750 $1.55 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Investment Management, LLC with notifications on news.